Arrowstreet Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.2M Buy
531,572
+389,761
+275% +$16.3M 0.01% 715
2026
Q1
$4.57M Buy
+141,811
New +$5.25M ﹤0.01% 1188
2025
Q3
– Sell
-325,524
Closed -$8.8M – 2124
2025
Q2
$8.8M Sell
325,524
-165,322
-34% -$4.79M 0.01% 942
2025
Q1
$14.6M Sell
490,846
-144,264
-23% -$5.5M 0.01% 696
2024
Q4
$25.2M Buy
635,110
+363,862
+134% +$13.8M 0.02% 532
2024
Q3
$9.23M Buy
+271,248
New +$7.63M 0.01% 774
2020
Q1
– Sell
-12,000
Closed -$335K – 2134
2019
Q4
$335K Buy
+12,000
New +$311K ﹤0.01% 1555

Other funds holding VCYT

Arrowstreet Capital's VCYT Position: Q2 2026 in Review

Arrowstreet Capital increased its Veracyte (VCYT) stake by 275% in Q2 2026, buying an estimated $16.3M and bringing the position to 531,572 shares worth $31.2M. The position accounts for 0.01% of the portfolio, ranked #715.

Arrowstreet Capital first reported a position in VCYT in Q4 2019 and has held it in 7 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Arrowstreet Capital held 531,572 shares of Veracyte worth $31.2M as of Q2 2026.
  • Arrowstreet Capital bought 389,761 Veracyte shares in Q2 2026, an estimated $16.3M.
  • Veracyte made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #715 holding.
  • Arrowstreet Capital first reported a position in Veracyte in Q4 2019 and has held it in 7 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.